Профиль компании · Healthcare

Progyny Inc

PGNY · США
Страна / Регион
USA
Дата IPO
25 октября 2019 г.
Сотрудники
835
Buffett Score
43/100
Слабоватый
Капитализация1,94 млрд $
Выручка (TTM)1,31 млрд $
EBITDA125,57 млн $
Чистая маржа6 %
ROE16,24 %
P/E (TTM)27,42
Прогнозный P/E11,85
Прибыль на акцию0,92 $
Диапазон за 52 недели16,10 $ – 33,07 $
Целевая цена аналитиков34,42 $
Рейтинг аналитиков4.6 / 5

Данные EODHD, показаны в валюте отчётности; только для справки, не является инвестиционной рекомендацией.

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

История

СкороЭтот раздел заполняется — загляните позже.

Положение в отрасли

СкороЭтот раздел заполняется — загляните позже.

Аналитики по этой бумаге на вашем языке пока нет.